Clinical interest in the lipoproteins stems mainly from the association between serum cholesterol concentrations and coronary heart disease. Investigations of lipoproteins should be performed in patients with premature coronary heart disease, with a strong family history of coronary heart disease, or with certain cutaneous stigmata of hyperlipoproteinaemia and when fasting serum samples are seen to be lipaemic. Family studies should be performed in appropriate cases to identify relatives at increased risk of developing coronary heart disease. Patients with conditions known to cause secondary hyperlipoproteinaemia should be investigated if they fall into one of these categories but only after treatment of the underlying condition. Non-specialist laboratories should be able to measure total cholesterol and triglyceride concentrations and high density lipoprotein cholesterol concentrations. Lipoprotein electrophoresis has a limited role in such laboratories and is not necessary as a routine procedure. Specialist laboratories should in addition be able to measure individual lipoproteins and identify apolipoprotein E phenotypes.
Introduction
The plasma lipoproteins contain cholesterol, triglyceride, and phospholipids completed with specific apoproteins. Chylomicrons, which are not normally present in fasting serum, and very low density lipoproteins (VLDL) carry most of the triglyceride; the triglyceride in chylomicrons is exogenous, being derived from dietary fat, while that in VLDL is endogenous, having been synthesised in the liver. The bulk of the cholesterol in plasma (roughly 80%) is transported in low density lipoprotein (LDL), with 15-20% in high density lipoprotein (HDL) and small amounts in VLDL and chylomicrons.
Triglyceride is an important energy substrate, while cholesterol is an essential component of the membranes of cells and organelles as well as being the precursor of steroid hormones. The major clinical interest in the lipoproteins, however, lies in the association, shown by epidemiological surveys, between increased plasma concentrations of both total and LDL cholesterol and the risk of development of coronary heart disease. Also, and independently, there is an association between coronary heart disease and a low concentration of HDL.' 2 The precise basis of these associations remains imperfectly understood, and other important risk factors for coronary heart disease exist-for example, smoking and hypertension. Hypertriglyceridaemia per se is probably not a risk factor for coronary heart disease," but it is often associated with reduced concentrations of HDL.
Hyperlipoproteinaemia may be primary'-that is, genetically determined-or secondary to other conditions such as hypothyroidism, diabetes mellitus, obesity, and excessive alcohol consumption. These other conditions may also exacerbate the lipid abnormalities in primary hyperlipoproteinaemia.
In whom should lipids be measured?
It is generally agreed that plasma lipid concentrations should be measured in (i) patients with evidence of premature coronary heart disease (that is, in those aged under 40); (ii) subjects with a strong family history of coronary heart disease; (iii) patients with xanthomas (but not xanthelasmas); and (iv) patients whose fasting serum is lipaemic. Measurement of cholesterol concentration may also be included in voluntary screening programmes available to men in the age group prone to coronary disease (25-65 years) to identify those at risk, who may then be offered appropriate treatment. Economic considerations preclude biochemical screening for hyperlipoproteinaemia except in these at risk groups. Although mild hypercholesterolaemia (>7-5 mmol/l; >290 mg/ 100 ml) is common, it is often related to both genetic and environmental factors, and whether its control would reduce the risk of coronary heart disease remains to be established. Mild hypertriglyceridaemia (>1 9, <4-0 mmol/l) (>190, <350 mg/ 100 ml) is also common and also often related to both genetic and environmental factors; it is of little clinical importance in the absence ofclinical manifestations (for example, xanthomas, lipaemia retinalis, recurrent abdominal pain), so screening for it cannot be justified.
Routine 18 Apolipoproteins-Although methods for measuring apolipoproteins are now available, there are few indications for their use except in research. Cross sectional studies in patients with proved coronary heart disease and controls have shown, for example, that apo-Al may be a better discriminator than HDL cholesterol for the presence of heart disease, whereas the data for apo-B in comparison with total LDL cholesterol are conflicting.'9 2 The relative merits of measuring apolipoproteins and lipoproteins as markers of the risk of coronary heart disease have not been elucidated2' and could be established conclusively only by long term prospective studies, the cost of which would probably be prohibitive. Measurement of apo-CII is required to diagnose apo-CII deficiency, a cause of the rare syndrome of fasting chylomicronaemia, although the management of this condition does not depend on knowledge of its cause.
Phenotyping of apo-E should be available for the definitive diagnosis of familial dysbetalipoproteinaemia, although, again, this is not necessary for management. In most patients with this condition the phenotype is E2/E2 and the total plasma apo-E concentration is raised."
Enzymes-An assay should be available to measure lipoprotein lipase, deficiency of which is a cause of fasting chylomicronaemia. The rare condition of deficiency of lecithin cholesterol acyl transferase requires that an assay for this enzyme should also be available. It is not necessary, however, for all specialised laboratories to be able to measure these enzymes, or the apolipoproteins, provided that they have access to these assays through cooperation with other laboratories.
Other tests-Future developments in the characterisation of lipoproteins may well provide clinically useful information. 'For example, women, who are less prone to coronary heart disease than men,24 have higher HDL2 concentrations than men, and men who survive myocardial infarction have lower HDL2 concentrations than apparently normal men.?5 This paper was prepared at the invitation 'of the clinical laboratory investigation working party of the scientific comminttee of the Association of Clinical Biochemists but does not necessarily reflect its views.
Conference Report Animal experiments JANE DAWSON
A recent cartoon in Private Eye shows a gang of hooded animal liberationists "rescuing" pairs of elephants and giraffes from the Ark as the deluge begins. A less lighthearted mark ofthe vehemence with which some representatives of the animal welfare lobby are prepared to pursue their ai was the unaccustomed policemen on duty on the steps ofthe Royal Society when a press seminar was held to correct what is seen by many researchers as the misinformation of the public by journalists. Since fewer than a third ofthose attending the meeting were press representatives (with only two from the national dailies) no immediate change is likely.
The press was said to be interested only in polarisation between reearchers and those whose antagonsm to animal expenments was expred as bomb threats. The low key, reasoned discussion of issues at the seminar between researchers and representatives from the RSPCA and moderate antivivisectionist organisations would make "bad television" said a man from the BBC.
Yet concern for animal welfare is increasing. The world's first professor of animal welfare has been appointed at Cambridge Scientists were criticised at the meeting for assuming that the media will intuitively understand research-aims and practices without special preparation and revision of the miAterial presented.
Misunderstanding and the violence faced by some research workers can breed a laager mentality, and this defensive attitude was seen by Professor Colin Blakemore as causing researchers to slip into the "silly pattern'm of emphasising potential applications of research work at the expense of basic research.
Knowledge of the promotion of carcinogenesis and of viral induction of carcinomas was derived almost entirely from work in
